Anosmia and ageusia in COVID-19: Updating its pathophysiology, diagnosis and treatment

Anosmia and ageusia in COVID-19: An update

  • Enrique Arturo Lombana Salas Autor
  • Moisés Andrés Lombana Salas
  • María Camila Miranda Jiménez
  • Michelle Bedoya Coronel
  • Wendy Yulieth Herazo Madera
  • Andrés Felipe Ducuara Hernández
Keywords: anosmia, ageusia, COVID19, sensory dysfunction

Abstract

Infection caused by the new coronavirus SARS-CoV-2 produces different clinical manifestations, including anosmia and ageusia, which can occasionally be persistent after the disappearance of other symptoms, which is the reason for the current review, with the aim of presenting the pathophysiology, diagnosis and management of these alterations in an updated manner. Through a search in scientific databases and worldwide recognized organisms in Health, evidence published since 2019 was compiled, where answers were found to new physiopathological bases that explain such disorders, such as the cofactor Neurolipin 1; and effective subjective methods for the diagnosis, as well as objective tests generally used by specialists, finally in terms of treatment there are described varieties ranging from olfactory training to the use of corticoids. In conclusion, the aspects studied related to the manifestations of COVID19 are constantly providing pathophysiological answers and therapeutic alternatives.

Downloads

Download data is not yet available.

Author Biographies

Enrique Arturo Lombana Salas, Autor

General Medical, University of Sucre, Sincelejo – Sucre- Colombia

Moisés Andrés Lombana Salas

5th Year Medical Student at the University of  Sucre, Sincelejo- Sucre- Colombia

María Camila Miranda Jiménez

5th Year Medical Student at the University of  Sucre, Sincelejo- Sucre- Colombia

Michelle Bedoya Coronel

5th Year Medical Student at the University of  Sucre, Sincelejo- Sucre- Colombia

Wendy Yulieth Herazo Madera

General Medical, University of Sucre, Sincelejo – Sucre- Colombia

Andrés Felipe Ducuara Hernández

5th Year Medical Student at the University of  Sucre, Sincelejo- Sucre- Colombia

References

1. PAHO. Coronavirus disease (COVID-19) | PAHO/WHO | Pan American Health Organization [Internet]. [cited 2021 June 28, 2021]. Available from: https://www.paho.org/es/enfermedad-por-coronavirus-covid-19
2. PAHO. COVID-19 status reports | PAHO/WHO | Pan American Health Organization [Internet]. [cited 2021 June 28, 2021]. Available from: https://www.paho.org/es/informes-situacion-covid-19
3. WHO. WHO publishes its first validation for emergency use of a COVID-19 vaccine and emphasizes the need for equitable global access [Internet]. [cited June 28, 2021]. Available from: https://www.who.int/es/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access
4. GLOBAL HEALTH STATISTICS 2021_20may.pdf [Internet]. [cited 2021 June 28, 2021]. Available from: https://cdn.who.int/media/docs/default-source/gho-documents/world-health-statistic-reports/2021/whs-2021_20may.pdf?sfvrsn=55c7c6f2_3
5. Las Casas Lima MH de, Cavalcante ALB, Leão SC. Pathophysiological relationship between COVID-19 and olfactory dysfunction: a systematic review. Braz J Otorhinolaryngol [Internet]. Apr 25, 2021 [cited 2021 Jun 28, 2021]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068782/.
6. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A review. JAMA. Aug 25, 2020;324(8):782-93.
7. Niazkar HR, Zibaee B, Nasimi A, Bahri N. The neurological manifestations of COVID-19: a review article. Neurol Sci. June 1, 2020;1-5.
8. Desai M, Oppenheimer J. The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice. J Allergy Clin Immunol Pract. Jan 2021;9(1):7-12.
9. Yom-Tov E, Lekkas D, Jacobson NC. Association of COVID19-induced anosmia and ageusia with depression and suicidal ideation. J Affect Disord Rep. July 1, 2021;5:100156.
10. Cofré AR, Cruz A, Garibotti G, Piccilli K, Abdelnur M, Gondou L, et al. OLFATIVE AND GUSTATIVE DYSFUNCTION IN PATIENTS WITH COVID-19 IN ARGENTINA. Rev Argent Salud Publica. April 2021;13:6-6.
11. Mastrangelo A, Bonato M, Cinque P. Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes. Neurosci Lett. Mar 23, 2021;748:135694.
12. Glezer I, Bruni-Cardoso A, Schechtman D, Malnic B. Viral infection and smell loss: the case of COVID-19. J Neurochem. 2021;157(4):930-43.
13. Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Berge KV den, Gong B, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. July 31, 2020;6(31):eabc5801.
14. Kerslake R, Hall M, Randeva HS, Spandidos DA, Chatha K, Kyrou I, et al. Coexpression of peripheral olfactory receptors with mediators of SARS-CoV-2 infection: possible implications beyond loss of olfaction as a symptom of COVID-19. Int J Mol Med. September 2020;46(3):949-56.
15. Singh M, Bansal V, Feschotte C. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors. Cell Rep. Sep 22, 2020;32(12):108175.
16. Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. Nov 13, 2020;370(6518):856-60.
17. Das G, Mukherjee N, Ghosh S. Neurological Insights of COVID-19 Pandemic. ACS Chem Neurosci. April 22, 2020;acschemneuro.0c00201.
18. Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2. J Virol. August 2008;82(15):7264-75.
19. Nakagawara K, Masaki K, Uwamino Y, Kabata H, Uchida S, Uno S, et al. Acute-onset olfactory/gustatory disorders are associated with elevated viral load in mild or asymptomatic SARS-CoV-2 infections. Int J Infect Dis. Oct 2020;99:19-22.
20. Eliezer M, Hamel A-L, Houdart E, Herman P, Housset J, Jourdaine C, et al. Loss of smell in patients with COVID-19: MRI data reveal a transient edema of the olfactory clefts. Neurology. Dec 8, 2020;95(23):e3145-52.
21. Saussez S, Lechien JR, Hopkins C. Anosmia: una evolución de nuestra comprensión de su importancia en COVID-19 y qué preguntas quedan por responder. Eur Arch Otorhinolaryngol. 9 de septiembre de 2020;1-5.
22. Laurendon T, Radulesco T, Mugnier J, Gérault M, Chagnaud C, Ahmadi A-AE, et al. Edema transitorio bilateral del bulbo olfativo durante la anosmia relacionada con COVID-19. Neurology. 4 de agosto de 2020;95(5):224-5.
23. de Melo GD, Lazarini F, Levallois S, Hautefort C, Michel V, Larrous F, et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med. 3 de mayo de 2021;eabf8396.
24. Boscutti A, Delvecchio G, Pigoni A, Cereda G, Ciappolino V, Bellani M, et al. Olfactory and gustatory dysfunctions in SARS-CoV-2 infection: A systematic review. Brain Behav Immun - Health. agosto de 2021;15:100268.
25. Bryche B, St Albin A, Murri S, Lacôte S, Pulido C, Ar Gouilh M, et al. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain Behav Immun. octubre de 2020;89:579-86.
26. Lovato A, Galletti C, Galletti B, de Filippis C. Clinical characteristics associated with persistent olfactory and taste alterations in COVID-19: Un informe preliminar sobre 121 pacientes. Am J Otolaryngol. 2020;41(5):102548.
27. Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Seguimiento de adultos con COVID-19 no crítico dos meses después del inicio de los síntomas. Clin Microbiol Infect. febrero de 2021;27(2):258-63.
28. Petersen MS, Kristiansen MF, Hanusson KD, Danielsen ME, á Steig B, Gaini S, et al. Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients. Clin Infect Dis Off Publ Infect Dis Soc Am. 30 de noviembre de 2020;ciaa1792.
29. Payne T, Kronenbuerger M, Wong G. Gustatory Testing. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 [citado 1 de julio de 2021]. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK567734/
30. Rebholz H, Braun RJ, Ladage D, Knoll W, Kleber C, Hassel AW. Loss of Olfactory Function-Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders. Front Neurol [Internet]. 2020 [citado 1 de julio de 2021];11. Disponible en: https://www.frontiersin.org/articles/10.3389/fneur.2020.569333/full
31. Vaira LA, Salzano G, Fois AG, Piombino P, Riu GD. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int Forum Allergy Rhinol. 2020;10(9):1103-4.
32. Neta FI, Fernandes ACL, Vale AJM, Pinheiro FI, Cobucci RN, Azevedo EP de, et al. Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19. Curr Res Pharmacol Drug Discov. 1 de enero de 2021;2:100035.
33. Eshraghi AA, Mirsaeidi M, Davies C, Telischi FF, Chaudhari N, Mittal R. Potential Mechanisms for COVID-19 Induced Anosmia and Dysgeusia. Front Physiol. 16 de septiembre de 2020;11:1039.
34. Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. Alta expresión del receptor ACE2 de 2019-nCoV en las células epiteliales de la mucosa oral. Int J Oral Sci. 24 de febrero de 2020;12:8.
35. Gong J, Dong H, Xia Q, Huang Z, Wang D, Zhao Y, et al. Análisis de correlación entre la gravedad de la enfermedad y los parámetros relacionados con la inflamación en pacientes con neumonía por COVID-19. medRxiv. 27 de febrero de 2020;2020.02.25.20025643.
36. Lozada-Nur F, Chainani-Wu N, Fortuna G, Sroussi H. Disgeusia en COVID-19: Possible Mechanisms and Implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 1 de septiembre de 2020;130(3):344-6.
37. Parra JD, Ripoll AP, Arias JFM. Nervios olfativo, trigeminal, facial, glosofaríngeo y vago: relación con el sars-cov-2 y perspectivas neurosemiológicas. Int J Med Surg Sci [Internet]. 14 de agosto de 2020 [citado 2 de julio de 2021];7(1). Disponible en: https://revistas.uautonoma.cl/index.php/ijmss/article/view/471
38. Printza A, Constantinidis J. The role of self-reported smell and taste disorders in suspected COVID-19. Eur Arch Otorhinolaryngol. 23 de mayo de 2020;1-6.
39. Romero-Gameros CA, Waizel-Haiat S, Mendoza-Zubieta V, Anaya-Dyck A, López-Moreno MA, Colin-Martinez T, et al. Evaluación del valor predictivo de la disfunción olfativa, como herramienta de cribado de COVID-19. Laryngoscope Investig Otolaryngol. 22 de octubre de 2020;5(6):983-91.
40. Lechien JR, Chiesa-Estomba MD CM, Hans S, Barillari MD MR, Jouffe L, Saussez S. Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19. Ann Intern Med. 26 de mayo de 2020;M20-2428.
41. Salmon Ceron D, Bartier S, Hautefort C, Nguyen Y, Nevoux J, Hamel A-L, et al. Self-reported loss of smell without nasal obstruction to identify COVID-19. The Coranosmia multicenter cohort study. J Infect. Oct 2020;81(4):614-20.
42. Lima MA, Silva MTT, Oliveira RV, Soares CN, Takano CL, Azevedo AE, et al. Olfactory dysfunction in patients with COVID-19: More than a yes-no question. J Neurol Sci. Nov 15, 2020;418:117107.
43. Gözen ED, Aliyeva C, Tevetoğlu F, Karaali R, Balkan İİ, Yener HM, et al. Evaluation of Olfactory Function With Objective Tests in COVID-19-Positive Patients: A Cross-Sectional Study. Ear Nose Throat J. November 25, 2020;0145561320975510.
44. Whitcroft KL, Hummel T. Olfactory Dysfunction in COVID-19: Diagnosis and Management. JAMA. June 23, 2020;323(24):2512.
45. Reichert JL, Schöpf V. Olfactory Loss and Regain: Lessons for neuroplasticity. The Neuroscientist. february 2018;24(1):22-35.
46. Kattar N, Do TM, Unis GD, Migneron MR, Thomas AJ, McCoul ED. Olfactory training for postviral olfactory dysfunction: systematic review and meta-analysis. Otolaryngol Neck Surg. Feb 1, 2021;164(2):244-54.
47. Agnieszka Sorokowsk. Effects of olfactory training: a meta-analysis. Rhinol J [Internet]. March 1, 2017 [cited July 5, 2021];55(1). Available from: http://www.rhinologyjournal.com/Abstract.php?id=1517
48. Addison AB, Wong B, Ahmed T, Macchi A, Konstantinidis I, Huart C, et al. Consensus statement of the Olfactory Clinical Working Group on the management of postinfectious olfactory dysfunction. J Allergy Clin Immunol. May 2021;147(5):1704-19.
49. Altundag A, Cayonu M, Kayabasoglu G, Salihoglu M, Tekeli H, Saglam O, et al. Modified olfactory training in patients with postinfectious olfactory loss. The Laryngoscope. 2015;125(8):1763-6.
50. Hopkins C, Alanin M, Philpott C, Harries P, Whitcroft K, Qureishi A, et al. Management of new-onset olfactory sensory loss during the COVID-19 pandemic - BRS consensus guidelines. Clin Otolaryngol. 2021;46(1):16-22.
51. Abdelalim AA, Mohamady AA, Elsayed RA, Elawady MA, Ghallab AF. Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial. Am J Otolaryngol. 2021;42(2):102884.
52. Vaira LA, Hopkins C, Petrocelli M, Lechien JR, Cutrupi S, Salzano G, et al. Efficacy of corticosteroid therapy in the treatment of long-standing olfactory disorders in patients with COVID-19. Rhinology. Feb 1, 2021;59(1):21-5.
53. Stafford LD, Orgill K. The effects of caffeine on olfactory function and mood: an exploratory study. Psychopharmacology (Berl). Dec 1, 2020;237(12):3511-7.
54. Reden J, Lill K, Zahnert T, Haehner A, Hummel T. Olfactory function in patients with postinfectious and posttraumatic smell disorders before and after treatment with vitamin A: A double-blind, placebo-controlled, randomized clinical trial. The Laryngoscope. 2012;122(9):1906-9.
55. Hura N, Xie DX, Choby GW, Schlosser RJ, Orlov CP, Seal SM, et al. Treatment of postviral olfactory dysfunction: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2020;10(9):1065-86.
56. Equils O, Lekaj K, Wu A, Fattani S, Liu G, Rink L. Intra-nasal zinc level relationship to COVID-19 anosmia and type 1 interferon response: a proposal. Laryngoscope Investig Otolaryngol. 2021;6(1):21-4.
57. Hummel T, Heilmann S, H??ttenbriuk K-B. Lipoic Acid in the Treatment of Smell Dysfunction Following Viral Infection of the Upper Respiratory Tract: The Laryngoscope. November 2002;112(11):2076-80.
58. Yan CH, Rathor A, Krook K, Ma Y, Rotella MR, Dodd RL, et al. Effect of Omega-3 Supplementation in Patients With Smell Dysfunction Following Endoscopic Sellar and Parasellar Tumor Resection: A Multicenter Prospective Randomized Controlled Trial. Neurosurgery. August 1, 2020;87(2):E91-8.
59. Whitcroft KL, Merkonidis C, Cuevas M, Haehner A, Philpott C, Hummel T. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia. Rhinology. Dec 1, 2016;54(4):368-74.
60. Whitcroft KL, Ezzat M, Cuevas M, Andrews P, Hummel T. The effect of intranasal sodium citrate on olfaction in post-infectious loss: results of a prospective, placebo-controlled trial in 49 patients. Clin Otolaryngol. 2017;42(3):557-63.
Published
2021-10-09
How to Cite
1.
Lombana Salas EA, Lombana Salas MA, Miranda Jiménez MC, Bedoya Coronel M, Herazo Madera WY, Ducuara Hernández AF. Anosmia and ageusia in COVID-19: Updating its pathophysiology, diagnosis and treatment. Int Arch BioMed Clin Res [Internet]. 2021Oct.9 [cited 2021Dec.1];7(3):GM1-GM7. Available from: http://iabcr.org/index.php/iabcr/article/view/741